FDA Investigator Rachel Collen
Rachel Collen has conducted inspections on 1 sites in 1 countries as of 21 Apr 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
21 Apr 2021
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Rachel Collen:
Amy E Devine,
Anthony R Bucks,
Aref Mel Demerdash,
Barbara I Rogolsky,
Brenda C Hamilton,
Brett R Havranek,
Carl A Huffman, III,
Chilton L Ng,
Cody D Rickman,
Cynthia L Evitt,
Cynthia M Goudeau,
Danial S Hutchison,
Daniel R Hurt,
Gwyn G Dickinson,
James D Planchon,
Jeannie M Vonderbrink,
Kellia N Hicks,
Lisa L Gilliam,
Mark S Ross,
Matthew R Sleeter,
Megan M Kirk,
Michele L Obert,
Minerva Rogers,
Neal L Adams,
Patrick L Wisor,
Raymond Valdivia,
Rebecca Rodriguez,
Robin K Hatfield,
Robin K Reel,
Shirley J Berryman,
Susanna E Ford,
Tara L Greene,
Tara L King,
Torrey M Ward,
Victoria A Wagoner,
Warren J Lopicka,
Zachary A Bogorad
Rachel Collen's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2002 | FDA 483 | Nostrum Laboratories, Inc. - Form 483, 2002-02-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more